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therapy including a vitamin K antagonist added to the classical dual anti-
platelet therapy. One patient died from a recurrent subdural haematoma,
another one had a peripheric embolism. 
Conclusions: In this prospective multicenter study, despite a dual anti-
platelet therapy, LV thrombus occured in 26% of patients after an anterior MI
complicated with LV dysfunction. Focused TTE has a high accuracy for their
detection.CMR-DE should be performed only in patients in whom the apex is
not clearly seen 
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Background and objective: Dobutamine stress echocardiography (DSE)
is being consistently used as an exercise-independent stress modality aimed
at the detection of coronary artery disease (CAD) and the evaluation of myo-
cardial ischemia. It may though occasionally induce coronary vasospasm. In
this study, we aimed to evaluate the prevalence and predictors of dobuta-
mine-related coronary spasm in patients without known CAD and false
positive DSE (positive DSE but no significant coronary lesions on angio-
gram) 
Methods: 3952 patients referred to our echocardiography laboratory for
DSE between January 2010 and May 2012 were prospectively investigated.
Those with positive DSE underwent coronary angiograms with systematic
methylergometrine intracoronary injection in case of absence of significant
coronary stenosis or spontaneous occlusive coronary spasm. Patients with
spontaneous occlusive coronary spasm or positive methylergometrine test but
no significant stenoses were enrolled and compared with those with positive
DSE but no coronary lesions nor spontaneous or induced spasm (« true » false
positive DSE)
Results: 29 patients with DSE-related vasospasm (19.4% of positive DSE
without known CAD) were compared with 56 patients with no lesions and no
spam (« true » false positive DSE). They were more frequently smokers
(72.4% vs 37.5%; p=0.003); they had more frequently dyslipidemia (79.3% vs
43%;p=0.001); they also had a larger ischemic area at peak DSE (3.4 vs 2.7
segments; p=0.05). 
On multivariate analysis, dyslipidemia (HR=10.7; 95% CI= [2.7-42.1];
p=0.001) and active smoking (HR=6.1; 95% CI= [1.7-21.1]; p=0.004) were
found to be independant predictors of spam-related DSE rather than « true »
false positive DSE. 
Conclusion: DSE- related coronary spasm is present in a significant pro-
portion of patients with erroneously labelled « false » positive DSE and should
systematically be ruled out. Dyslipidemia and active smoking were indepen-
dant predictors of spasm rather than « true » false positive DSE 
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Objective: of the study is to compare the longitudinal strain values in
patients with bicuspid aortic valve (BAV) disease in comparison to degenera-
tive aortic stenosis and regurgitation, and control population.
Methods: Patients with BAV and tricuspid degenerative aortic valve were
selected in the absence of 1) left ventricular (LV) dysfunction, 2) history of
myocardial infarction and 3) atrial fibrillation. The study included 48 patients
with isolated BAV (54±19 years, 25% [n=12] with significant aortic stenosis),
30 isolated degenerative aortic stenosis or regurgitation (77±11 years, 26%
[n=8] with significant aortic stenosis and 30 healthy control subjects (48±15
years). Patient global longitudinal strain was computed from apical views
using speckle tracking analysis (EchoPAC, GE). 
Results: Left ventricular ejection fraction was similar in BAV (62±6%),
degenerative (63±6%) and control groups (62±3%). In contrast, longitu-
dinal global strain was more impaired in BAV (–19±2%) than in dege-
nerative (–20±2%, P=0.04) and control groups (–21±2, P<0.001), even in
BAV patients without significant aortic valve disease (–19±2% for BAV vs.
–20±2% for degenerative, P=0.01). Interestingly, longitudinal global strain
was similar between degenerative group without significant aortic stenosis
and control (–20±2% vs. –21±2%, P=0.5) 
Conclusion: Impaired longitudinal strain in BAV patients is observed inde-
pendently of the presence of significant aortic valve disease while in degener-
ative group longitudinal strain is only impaired in the presence of significant
aortic stenosis. These results suggest the presence of a structural myocardial
disease in BAV disease.
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Introduction: Invasive hemodynamic procedures are still necessary to appre-
ciate pulmonary hypertension characteristics. A few studies have adressed the
issue of echocardiographic evaluation, but lack an external validation of their
results with various settings and patients. The aim of our study was to appreciate
the value of 2 published echocardiographic evaluations of pulmonary vascular
resistances (PVR) based on tricuspid regurgitation maximal velocity (TRV) and
right ventricular outflow tract systolic time velocity integral (TVI).
Methods: All of the patients presenting during 2013 for invasive haemo-
dynamic evaluation with a suspected pulmonary hypertension were prospec-
tively included, with echocardiography being done within 24 hours of
catheterization. The TRV/TVI and TRV2/TVI ratio and echographic estima-
tions of PVR were compared with catheter values; predictive values to detect
elevated PVR were assessed.
Results: 43 patients were included, 12 with atrial fibrillation, 16 with val-
vular disease, 14 with hypertrophic cardiopathy. Mean pulmonary pressure
was 41±11 mmHg. TRV/TVI and TRV2/TVI were correlated with PVR
(r=0.71 and r=0.78 respectively, p<0.01). Using TRV2/TVI, a cutpoint value
of 0.98 had a specificity of 86% and a sensitiviy of 80% to predict PVR over
6 UW. Estimation of PVR with the previously published formula PVR = 5,19
TRV2/TVI – 0.4 was 100% correct to predict an PVR under 3 UW and 93%
correct to predict an PVR over 6 UW.
Conclusion: Our results confirm the value of echocardiographic measure-
ment of TRV2/TVI to evaluate PVR in a routine fashion for a non-selected
population with high pulmonary pressure (figure next page). 
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Background: Management of increased referrals for echocardiography exami-
nations is a daily challenge. Compared to transthoracic exploration, transesopha-
geal echocardiography (TEE) is semi-invasive, and is more time consuming.
Mainly based on expert consensus Appropriate Use Criteria guidelines for echo-
cardiography (AUC) have been recently published. However, the ability of these
criteria to predict the actual usefulness of TEE have not been yet well explored.
Aim: To investigate the ability of AUC to predict the actual usefulness of
TEE in daily clinical practice.
